Financial statements Opti-Pharm
Balance sheet data of OPTI-PHARM
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|---|---|---|---|---|---|
Total assets | 616 589,65 | 874 164,85 | 1 175 348,47 | 1 412 014,30 | 1 727 360,11 | 1 986 522,58 |
A. Fixed assets | 14 746,00 | 12 793,76 | 11 628,16 | 11 432,80 | 11 237,44 | 11 042,08 |
B. Current assets | 601 843,65 | 861 371,09 | 1 163 720,31 | 1 400 581,50 | 1 716 122,67 | 1 975 480,50 |
C. Share capital contributions (basic funds) | - | - | - | - | - | - |
D. Own shares (stocks) | - | - | - | - | - | - |
Total liabilities | 616 589,65 | 874 164,85 | 1 175 348,47 | 1 412 014,30 | 1 727 360,11 | 1 986 522,58 |
A. Equity | 88 053,70 | 253 436,99 | 678 324,92 | 963 951,84 | 1 137 278,12 | 1 431 913,86 |
B. Liabilities and provisions for liabilities | 528 535,95 | 620 727,86 | 497 023,55 | 448 062,46 | 590 081,99 | 554 608,72 |
I. Long-term liabilities | - | - | - | - | - | - |
II. Short-term liabilities | - | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.